859 Initial Control of Acid Reflux After Laparoscopic Anti-Reflux Surgery (Lars) Compared to Chronic Use of Esomeprazole (ESO) 20-40mg Daily

Jan Gunnar Hatlebakk(Haukeland University Hospital), Ola Junghard(AstraZeneca (Sweden)), Christian Ell(Johannes Gutenberg University Mainz), Stephen E. Attwood(Durham University), Lars Lundell(Karolinska Institutet), Tore Lind(Skaraborg Hospital), Jean Paul Galmiche(Centre Hospitalier Universitaire de Nantes), Roberto Fiocca(Alleanza Contro il Cancro)

Gastroenterology

April 1, 2008

10.1016/s0016-5085(08)60584-3

Cited by 1

Related Papers

Esophageal eosinophilia with dysphagia

|Digestive Diseases and Sciences|1993|889

Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I Study

|Helicobacter|1996|575

A critical review of the diagnosis and management of Barrett’s esophagus: the AGA Chicago Workshop1 1Members of the workshop composed a group of international experts in BE from gastroenterology, surgery, pathology, molecular biology, outcomes, and epidemiology. Conference chairman: Prateek Sharma; conference moderator: Kenneth McQuaid; group leaders: John Dent, M. Brian Fennerty, Richard Sampliner, Stuart Spechler; participants: Alan Cameron, Douglas Corley, Gary Falk, John Goldblum, John Hunter, Janusz Jankowski, Lars Lundell, Brian Reid, Nicholas Shaheen, Amnon Sonnenberg, Kenneth Wang, and Wilfred Weinstein.

|Gastroenterology|2004|526

The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies

|Gastroenterology|1999|433

Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process

|Gastroenterology|2012|378